These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34949299)

  • 21. Snapshot from Durban: new antiretroviral agents.
    Sterling TR
    Hopkins HIV Rep; 2000 Sep; 12(4):13. PubMed ID: 12184239
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of clinical pharmacists in outpatient HIV clinics.
    Cantwell-McNelis K; James CW
    Am J Health Syst Pharm; 2002 Mar; 59(5):447-52. PubMed ID: 11887411
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiretroviral medication knowledge among New York State pharmacists: room for improvement.
    Jodlowski TZ; Sym D; Conry J; Kanmaz T
    J Pharm Pract; 2010 Oct; 23(5):507-10. PubMed ID: 21507855
    [No Abstract]   [Full Text] [Related]  

  • 24. Shortcomings of adherence counselling provided to caregivers of children receiving antiretroviral therapy in rural South Africa.
    Coetzee B; Kagee A; Bland R
    AIDS Care; 2016 Mar; 28 Suppl 2(sup2):60-5. PubMed ID: 27392000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inevitability of antiretrovirals.
    S Afr Med J; 2003 Aug; 93(8):572. PubMed ID: 14531106
    [No Abstract]   [Full Text] [Related]  

  • 26. Why don't patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS.
    Penn C; Watermeyer J; Evans M
    Patient Educ Couns; 2011 Jun; 83(3):310-8. PubMed ID: 21474263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.
    Klausner JD; Serenata C; O'Bra H; Mattson CL; Brown JW; Wilson M; Mbengashe T; Goldman TM
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):292-5. PubMed ID: 21317587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.
    Bobat R; Kindra G; Kiepiela P; Reddy S; Jeena PM; Adhikari M; Coovadia HM
    Pediatr Infect Dis J; 2010 Sep; 29(9):890. PubMed ID: 20720476
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients.
    Heelon M; Skiest D; Tereso G; Meade L; Weeks J; Pekow P; Rothberg MB
    Am J Health Syst Pharm; 2007 Oct; 64(19):2064-8. PubMed ID: 17893418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication errors in HIV-infected hospitalized patients: a pharmacist's impact.
    Eginger KH; Yarborough LL; Inge LD; Basile SA; Floresca D; Aaronson PM
    Ann Pharmacother; 2013; 47(7-8):953-60. PubMed ID: 23737513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hungering for HAART.
    Montaner JS; Hogg RS
    Ann Intern Med; 2007 Apr; 146(8):609-10. PubMed ID: 17438321
    [No Abstract]   [Full Text] [Related]  

  • 33. The state attitude to antiretroviral treatment--the doctor's duty to speak out.
    Donna Knapp VB; Dhai A; van Bogaert LJ; Howarth G; Hanekom D; Ogunbanjo G
    S Afr Med J; 2002 Apr; 92(4):272-3. PubMed ID: 12056350
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa.
    Murphy RA; France H; Sunpath H; Gordon ML; Marconi VC; Kuritzkes DR; McIntosh K
    J Trop Pediatr; 2009 Feb; 55(1):60-2. PubMed ID: 18786985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral therapy in children--increased benefit from increased complexity.
    Cotton MF
    S Afr Med J; 2000 Oct; 90(10):985-8. PubMed ID: 11081099
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.
    Lutz S; Heberling M; Goodlet KJ
    J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action.
    Jarvis JN; Lawn SD; Wood R; Harrison TS
    Clin Infect Dis; 2010 Dec; 51(12):1463-5. PubMed ID: 21082878
    [No Abstract]   [Full Text] [Related]  

  • 39. A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa.
    Le Roux KW; Davis EC; Gaunt CB; Young C; Koussa M; Harris C; Rotheram-Borus MJ
    AIDS Patient Care STDS; 2019 Nov; 33(11):466-472. PubMed ID: 31682167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa.
    Larson E; Bendavid E; Tuoane-Nkhasi M; Mbengashe T; Goldman T; Wilson M; Klausner JD
    Int J STD AIDS; 2014 Aug; 25(9):636-42. PubMed ID: 24352117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.